For example, Paclitaxel, Vinorelbine, Gemcitabine and Epirubicin are commonly used drugs to treat breast cancer, the expression levels of IL18 were negatively associated with tumor cell sensitivity to Paclitaxel, Vinorelbine and Epirubicin. Here, IL18 is linked to neoplasm.